1. Home
  2. PRG vs BLFS Comparison

PRG vs BLFS Comparison

Compare PRG & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROG Holdings Inc.

PRG

PROG Holdings Inc.

N/A

Current Price

$39.49

Market Cap

1.7B

ML Signal

N/A

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

N/A

Current Price

$35.19

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRG
BLFS
Founded
2020
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
PRG
BLFS
Price
$39.49
$35.19
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$50.00
$32.00
AVG Volume (30 Days)
431.0K
687.2K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.45%
N/A
EPS Growth
N/A
77.27
EPS
1.80
0.94
Revenue
$2,409,223,000.00
$96,214,000.00
Revenue This Year
$23.77
$19.73
Revenue Next Year
$7.91
$17.82
P/E Ratio
$21.51
$37.58
Revenue Growth
N/A
16.97
52 Week Low
$25.80
$17.86
52 Week High
$47.73
$38.10

Technical Indicators

Market Signals
Indicator
PRG
BLFS
Relative Strength Index (RSI) 39.71 53.76
Support Level $38.13 $23.93
Resistance Level $41.14 $38.10
Average True Range (ATR) 1.15 1.07
MACD -0.15 -0.38
Stochastic Oscillator 26.57 17.16

Price Performance

Historical Comparison
PRG
BLFS

About PRG PROG Holdings Inc.

PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: